Page last updated: 2024-09-04

phosphorus and gs 4071

phosphorus has been researched along with gs 4071 in 1 studies

Compound Research Comparison

Studies
(phosphorus)
Trials
(phosphorus)
Recent Studies (post-2010)
(phosphorus)
Studies
(gs 4071)
Trials
(gs 4071)
Recent Studies (post-2010) (gs 4071)
48,0741,12617,13919016140

Protein Interaction Comparison

ProteinTaxonomyphosphorus (IC50)gs 4071 (IC50)
Neuraminidase Influenza A virus (A/Turkey/651242/2006(H5N1))1.4208
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))0.4952
Neuraminidase Influenza A virus (A/duck/Laos/25/2006(H5N1))1.63
NeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))0.0175
NeuraminidaseInfluenza A virus (A/USSR/90/1977(H1N1))0.0079
NeuraminidaseInfluenza A virus (A/Wilson-Smith/1933(H1N1))0.1851
NeuraminidaseInfluenza A virus (A/Memphis/1/1971(H3N2))0.0039
NeuraminidaseInfluenza B virus (B/Lee/1940)0.0085
NeuraminidaseInfluenza A virus (A/udorn/1972(H3N2))0.5813
SialidaseClostridium perfringens0.001
Substance-P receptorCavia porcellus (domestic guinea pig)0.015
Histamine H1 receptorCavia porcellus (domestic guinea pig)2.8247
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0089
NeuraminidaseInfluenza A virus (A/duck/Ukraine/1/1963(H3N8))0.0089
Neuraminidase Influenza A virus (A/udorn/1972(H3N2))0.0029
Substance-K receptorCavia porcellus (domestic guinea pig)0.015
NeuraminidaseInfluenza A virus (A/swine/Hong Kong/127/1982(H3N2))0.17
Neuraminidase Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1))0.0007
NeuraminidaseInfluenza A virus (A/budgerigar/Hokkaido/1/1977(H4N6))0.0153
Integrase Human immunodeficiency virus 11.785

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barr, JJ; Bond, PL; Singer, AC; Slater, FR; Turner, S1

Other Studies

1 other study(ies) available for phosphorus and gs 4071

ArticleYear
Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (TamifluĀ®) and loss of nutrient removal performance.
    FEMS microbiology letters, 2011, Volume: 315, Issue:1

    Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Biodegradation, Environmental; Bioreactors; Microbial Consortia; Models, Biological; Oseltamivir; Pandemics; Particle Size; Phosphorus; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification

2011